RemeGen Co., Ltd., a commercial-ready biotechnology company, announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic...
Astellas Pharma Inc. and Dyno Therapeutics, Inc. announced an option and license agreement was signed on November 23 to develop next-generation adeno-associated virus (AAV)...
Lunit, a leading medical AI provider, announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company's planned public offering on...
Based in Denver, Colorado, Mydecine innovations Group is a biotechnology and c company specialising in innovative, novel therapeutics for the treatment of certain mental health...
Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound, mocravimod, announces the appointment of Elisabeth Kueenburg, M.D.,...
